The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

The liquid biopsy market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of more than 30%, as per The Business Research Company’s market report!

Read More On The Liquid Biopsy Market Report 2022 – https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report

The Liquid Biopsy Market Size In 2022 And Forecast

The global liquid biopsy market is expected to grow from $4.02 billion in 2021 to $5.17 billion in 2022 at a compound annual growth rate (CAGR) of 28.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The liquid biopsy market is expected to reach $15.01 billion in 2026 at a CAGR of 30.6%.

The liquid biopsy market consists of sales of liquid biopsy services and related products used to detect cancer at an early stage.

Request for A Sample Of The Global Liquid Biopsy Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp

Government Funds For Refining Cancer Detection Is Driving The Growth Of The Liquid Biopsy Market

For instance, in 2019, National Cancer Institute (NCI), a USA-based government agency gave funds worth $2.1 million and a five-year grant to Translational Genomics Research Institute (TGen), a genomics research institute based in the U.S.A. The funding enables TGen and Mayo Clinic researchers to drive the clinical trials for liquid biopsy tests for the detection of breast cancer. The National Cancer Institute (NCI) aims to post a Funding Opportunity Announcement (FOA) in December 2020 to enable applications for cancer diagnosis, prevention, identification, and treatment innovations for public health (U01 activity code). The FAO has projected that the overall funding is expected to hit $4 million in the fiscal year 2022. Therefore, government funds positively impact the growth of the liquid biopsy market.

Competitive Landscape And The Regional Analysis Of The Liquid Biopsy Market

Major players in the liquid biopsy market are QIAGEN N.V., Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific, Guardant Health, Menarini Silicon Biosystems, Biocept Inc., F. Hoffmann-La Roche AG, Janssen Diagnostics LLC., Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Cygnus Biosciences, Illumina Inc., Oxford Nanopore, and Quantum Biosystems.

The Liquid Biopsy Global Market Report 2022 covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the liquid biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the 3D cell culture technologies market.

New Product Launches – A Key Trend In The Liquid Biopsy Market

Companies are rapidly adopting new market dynamics and focusing primarily on new product launches, to meet the ever-increasing need for liquid biopsy products and services, to increase their revenue, and also for gaining a competitive edge over their rivals.

Liquid Biopsy Market Segmentation By The Business Research Company

1) By Product: Assays Kits, Instruments, Services

2) By End User: Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers

3) By Clinical Application: Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics

Here Are Some Reports Related To The Liquid Biopsy Market –

Biopsy Devices Global Market Report 2022

Interventional Radiology Global Market Report 2022

Cancer Diagnostics Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: